Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis? Sameer DamleChristine B. Teal Breast Oncology Open access 24 September 2009 Pages: 3215 - 3216
Peritoneal Dissemination: A Pending Issue in Gastric Cancer Worth Exploring Santiago González-Moreno Gastrointestinal Oncology Open access 24 September 2009 Pages: 3217 - 3218
Outcome of Low-Volume Surgery for Esophageal Cancer in a High-Volume Referral Center Ewout F. W. Courrech StaalFrits van CoevordenJohanna W. van Sandick Healthcare Policy and Outcomes 24 September 2009 Pages: 3219 - 3226
Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination Hiroshi OkabeShugo UedaYoshiharu Sakai Gastrointestinal Oncology 24 September 2009 Pages: 3227 - 3236
Esophagogastric Junction Adenocarcinoma According to Siewert Classification in Taiwan Wen-Liang FangChew-Wun WuWing-Yiu Lui Gastrointestinal Oncology 28 July 2009 Pages: 3237 - 3244
Better 5-Year Survival Rate Following Curative Gastrectomy in Overweight Patients Masanori TokunagaNaoki HikiToshifusa Nakajima Gastrointestinal Oncology 28 July 2009 Pages: 3245 - 3251
The Safety of the Dissection of Lymph Node Stations 5 and 6 in Pylorus-Preserving Gastrectomy Seong-Ho KongJong Won KimHan-Kwang Yang Gastrointestinal Oncology 29 July 2009 Pages: 3252 - 3258
Notch2 Expression Is Decreased in Colorectal Cancer and Related to Tumor Differentiation Status Dake ChuJianyong ZhengGang Ji Colorectal Cancer 04 August 2009 Pages: 3259 - 3266
Intramucosal Carcinoma on Biopsy Reliably Predicts Invasive Colorectal Cancer Alastair W. MacDonaldMuhammad TayyabJohn R. T. Monson Colorectal Cancer 10 October 2009 Pages: 3267 - 3270
Extended Lymph Node Dissection for Rectal Cancer with Radiologically Diagnosed Extramesenteric Lymph Node Metastasis Byung Soh MinJin Soo KimSeung Kook Sohn Colorectal Cancer 18 September 2009 Pages: 3271 - 3278
Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases Christoph ReissfelderNuh N. RahbariJürgen Weitz Hepatobiliary Tumors 18 August 2009 Pages: 3279 - 3288
Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver Cirrhosis Roberto SantambrogioEnrico OpocherMarco Montorsi Hepatobiliary and Pancreatic Tumors 01 September 2009 Pages: 3289 - 3298
Long-Term Results of Hepatic Resection Combined with Intraoperative Local Ablation Therapy for Patients with Multinodular Hepatocellular Carcinomas Shinji ItohKazutoyo MoritaYoshihiko Maehara Hepatobiliary Tumors 14 October 2009 Pages: 3299 - 3307
Initial Presentation and Management of Hilar and Peripheral Cholangiocarcinoma: Is a Node-Positive Status or Potential Margin-Positive Result a Contraindication to Resection? Kevin Tri NguyenJennifer SteelT. Clark Gamblin Hepatobiliary and Pancreatic Tumors 23 September 2009 Pages: 3308 - 3315
Resectable Pancreatic Cancer: Who Really Benefits From Resection? Giuliano BarugolaStefano PartelliMassimo Falconi Pancreatic Tumors 26 August 2009 Pages: 3316 - 3322
Prognostic Significance of Lymph Node Metastases in Pancreatic Head Cancer Treated with Extended Lymphadenectomy: Not Just a Matter of Numbers Paolo MassuccoDario RiberoLorenzo Capussotti Pancreatic Tumors 24 September 2009 Pages: 3323 - 3332
Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection Kaitlyn J. KellyJoyce WongDaniel Coit Pancreatic Tumors 18 September 2009 Pages: 3333 - 3339
Survival Data Justifies Resection for Pancreatic Metastases Oliver StrobelThilo HackertJens Werner Pancreatic Tumors 24 September 2009 Pages: 3340 - 3349
Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient Sylvie BonvalotFrançoise RimareixJane Muret Bone and Soft Tissue Sarcomas 15 October 2009 Pages: 3350 - 3357
Treatment and Outcomes in Adult Patients with Primary Cardiac Sarcoma: The British Columbia Cancer Agency Experience Pauline T. TruongStuart O. JonesSharon J. Allan Bone and Soft Tissue Sarcomas 15 October 2009 Pages: 3358 - 3365
Axillary Lymph Node Dissection for Sentinel Lymph Node Micrometastases May Be Safely Omitted in Early-Stage Breast Cancer Patients: Long-Term Outcomes of a Prospective Study Igor LangerUlrich GullerMarkus Zuber Breast Oncology 04 September 2009 Pages: 3366 - 3374
Risk Factors Associated with Conversion from Nonmalignant to Malignant Diagnosis After Surgical Excision of Breast Papillary Lesions Tsung-Yen ChengChii-Ming ChenChung-Wei Lin Breast Oncology 30 July 2009 Pages: 3375 - 3379
Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? Carlos A. Garcia-EtienneMonica BarileBernardo Bonanni Breast Oncology 01 August 2009 Pages: 3380 - 3387
Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer Hassan A. HatoumFaek R. JamaliAli I. Shamseddine Breast Oncology 05 August 2009 Pages: 3388 - 3395
The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer S. David NathansonDavid KwonDhananjay Chitale Breast Oncology 06 August 2009 Pages: 3396 - 3405
Early Results of an Endoscopic Nipple-Sparing Mastectomy for Breast Cancer Naomi SakamotoEisuke FukumaMitsuhiro Tozaki Breast Oncology 07 August 2009 Pages: 3406 - 3413
Prognostic Factors in 77 Curative Chest Wall Resections for Isolated Breast Cancer Recurrence Carmen C. van der PolAlbertus N. van GeelTitia E. Lans Breast Oncology Open access 12 August 2009 Pages: 3414 - 3421
Analysis of Contemporary Trends in Access to High-Volume Ovarian Cancer Surgical Care Robert E. BristowIsha PuriDeborah K. Armstrong Gynecologic Oncology 27 August 2009 Pages: 3422 - 3430
Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study Mauro SignorelliAndrea Alberto LissoniRoldano Fossati Gynecologic Oncology 16 October 2009 Pages: 3431 - 3441
Treatment Strategy of Papillary Thyroid Carcinoma in Children and Adolescents: Clinical Significance of the Initial Nodal Manifestation Nobuyuki WadaKiminori SuginoKoichi Ito Endocrine Tumors 24 September 2009 Pages: 3442 - 3449
Utility of Intraoperative PTH for Primary Hyperparathyroidism Due to Multigland Disease Ashley K. CayoRebecca S. SippelHerbert Chen Endocrine Tumors 04 September 2009 Pages: 3450 - 3454
S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients S. KruijffE. BastiaannetH. J. Hoekstra Melanomas Open access 28 July 2009 Pages: 3455 - 3462
Isolated Limb Infusion for Malignant Melanoma: Predictors of Response and Outcome Andrew P. BarbourJanine ThomasB. Mark Smithers Melanomas 15 October 2009 Pages: 3463 - 3472
CD98 Expression Is Associated with Poor Prognosis in Resected Non-Small-Cell Lung Cancer with Lymph Node Metastases Kyoichi KairaNoboru OriuchiMasatomo Mori Thoracic Oncology 24 September 2009 Pages: 3473 - 3481
Ambulatory Intercostal Drainage for the Management of Malignant Pleural Effusion: A Single Center Experience Samer BazerbashiJaime VillaquiranAdrian Marchbank Thoracic Oncology 24 September 2009 Pages: 3482 - 3487
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy Susumu SaigusaKoji TanakaMasato Kusunoki Translational Research and Biomarkers 06 August 2009 Pages: 3488 - 3498
IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis Dawei LiDongwang YanZhihai Peng Translational Research and Biomarkers 12 August 2009 Pages: 3499 - 3506
RGS16 Is a Marker for Prognosis in Colorectal Cancer Norikatsu MiyoshiHideshi IshiiMasaki Mori Translational Research and Biomarkers 04 September 2009 Pages: 3507 - 3514
